Trademark Snap Shot Publication Stylesheet (Table presents the data on Publication Approval) |
|||
OVERVIEW |
|||
SERIAL NUMBER | 88355281 | FILING DATE | 03/25/2019 |
REG NUMBER | 0000000 | REG DATE | N/A |
REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
INTL REG # | N/A | INTL REG DATE | N/A |
TM ATTORNEY | LAWRENCE, SUSAN KASTRI |
L.O. ASSIGNED | 116 |
PUB INFORMATION |
|||
RUN DATE | 01/30/2020 | ||
PUB DATE | N/A | ||
STATUS | 680-APPROVED FOR PUBLICATION | ||
STATUS DATE | 01/29/2020 | ||
LITERAL MARK ELEMENT | STRANDSMART | ||
DATE ABANDONED | N/A | DATE CANCELLED | N/A |
SECTION 2F | NO | SECTION 2F IN PART | NO |
SECTION 8 | NO | SECTION 8 IN PART | NO |
SECTION 15 | NO | REPUB 12C | N/A |
RENEWAL FILED | NO | RENEWAL DATE | N/A |
DATE AMEND REG | N/A |
FILING BASIS |
|||||
FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
44D | NO | 44D | NO | 44D | NO |
44E | NO | 44E | NO | 44E | NO |
66A | NO | 66A | NO | ||
NO BASIS | NO | NO BASIS | NO |
MARK DATA |
|
STANDARD CHARACTER MARK | YES |
LITERAL MARK ELEMENT | STRANDSMART |
MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
PARTY TYPE | 10-ORIGINAL APPLICANT |
NAME | StrandSmart, Inc. |
ADDRESS | c/o Adrianna Davies 100 Van Ness, Suite 1612 San Francisco, CA 94102 |
ENTITY | 03-CORPORATION |
CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
INTERNATIONAL CLASS | 005 |
DESCRIPTION TEXT | Diagnostic testing devices, namely, diagnostic kits comprised of a cartridge with microelectrodes therein, each microelectrode having a carbon nanotube film with cancer-specific antibodies or other targeting materials thereon for testing blood samples for detection of cancers, specifically breast cancer, colon cancer, lung cancer, pancreatic cancer and prostate cancer; Diagnostic kits comprised of cartridges with microelectrodes therein, each microelectrode having a carbon nanotube film with cancer-specific antibodies or other targeting materials thereon for use with an analysis device for testing of blood for detecting cancers in blood samples, specifically breast cancer, colon cancer, lung cancer, pancreatic cancer and prostate cancer |
INTERNATIONAL CLASS | 010 |
DESCRIPTION TEXT | Medical devices, namely, diagnostic kits consisting primarily of apparatus with microelectrodes therein, each microelectrode having a carbon nanotube film for use with cancer-specific antibodies or other targeting materials thereon, for analyzing blood samples for detecting cancers in blood samples, specifically breast cancer, colon cancer, lung cancer, pancreatic cancer and prostate cancer; Diagnostic testing devices, namely, diagnostic kits comprised of apparatus with microelectrodes therein, each microelectrode having a carbon nanotube film for use with cancer-specific antibodies or other targeting materials thereon, and an analysis device for testing blood samples for detection of cancers, specifically breast cancer, colon cancer, lung cancer, pancreatic cancer and prostate cancer |
GOODS AND SERVICES CLASSIFICATION |
|||||||
INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 010 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
CHANGE IN REGISTRATION | NO |
PSEUDO MARK | STRAND SMART |
PROSECUTION HISTORY |
||||
DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
01/29/2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 018 |
01/29/2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 017 |
01/29/2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 016 |
01/28/2020 | ALIE | A | ASSIGNED TO LIE | 015 |
01/21/2020 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | 014 |
12/17/2019 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | 013 |
12/17/2019 | GNFR | O | FINAL REFUSAL E-MAILED | 012 |
12/17/2019 | CNFR | R | FINAL REFUSAL WRITTEN | 011 |
12/05/2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 010 |
12/04/2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 009 |
12/04/2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 008 |
12/04/2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 007 |
06/04/2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 006 |
06/04/2019 | GNRT | F | NON-FINAL ACTION E-MAILED | 005 |
06/04/2019 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
06/04/2019 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
04/11/2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
03/28/2019 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
ATTORNEY | Raymond Van Dyke |
CORRESPONDENCE ADDRESS | Raymond Van Dyke VAN DYKE LAW WASHINGTON SQUARE, PO BOX 65302 1050 CONNECTICUT AVENUE NW WASHINGTON DC 20035 |
DOMESTIC REPRESENTATIVE | NONE |